Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
5.05
-0.32 (-5.96%)
Apr 29, 2026, 9:33 AM EDT - Market open
Quantum BioPharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
31.54M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 40.58M |
| Dyadic International | 3.09M |
| IGC Pharma | 1.11M |
| Daré Bioscience | 1.03M |
| Senti Biosciences Holdings | 22.00K |
QNTM News
- 1 day ago - Quantum BioPharma Provides Corporate Update - GlobeNewsWire
- 7 days ago - Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - GlobeNewsWire
- 4 weeks ago - Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - GlobeNewsWire
- 4 weeks ago - Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis - GlobeNewsWire
- 4 weeks ago - Quantum Biopharma Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status - GlobeNewsWire
- 5 weeks ago - Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd - GlobeNewsWire
- 5 weeks ago - Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering - GlobeNewsWire